Catalyst Wire Dossier Catalyst Wire Dossier

existing anti-VEGF therapies

anti-VEGF therapy
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for existing anti-VEGF therapies, covering 2014-01-27 to 2014-01-27. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Effectiveness of Existing Anti vascUlar Endothelial Growth Factor (Anti VEGF) in Patients With Wet Age-related Macular Degeneration (wAMD) (AURA)

See pricing